Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G iBio, Inc. Filed by: Coastlands Capital LP

October 14, 2026 11:57 AM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 6,247,738 shares of Common Stock held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 64,307,256 shares outstanding as of August 27, 2026, as disclosed in the Annual Report on Form 10-K filed by the Issuer on August 28, 2026. Excludes pre-funded warrants and warrants held by the Reporting Persons in excess of a beneficial ownership limitation of 4.99%.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 6,247,738 shares of Common Stock held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 64,307,256 shares outstanding as of August 27, 2026, as disclosed in the Annual Report on Form 10-K filed by the Issuer on August 28, 2026. Excludes pre-funded warrants and warrants held by the Reporting Persons in excess of a beneficial ownership limitation of 4.99%.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 6,247,738 shares of Common Stock held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 64,307,256 shares outstanding as of August 27, 2026, as disclosed in the Annual Report on Form 10-K filed by the Issuer on August 28, 2026. Excludes pre-funded warrants and warrants held by the Reporting Persons in excess of a beneficial ownership limitation of 4.99%.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 6,247,738 shares of Common Stock held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 64,307,256 shares outstanding as of August 27, 2026, as disclosed in the Annual Report on Form 10-K filed by the Issuer on August 28, 2026. Excludes pre-funded warrants and warrants held by the Reporting Persons in excess of a beneficial ownership limitation of 4.99%.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 6,247,738 shares of Common Stock held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 64,307,256 shares outstanding as of August 27, 2026, as disclosed in the Annual Report on Form 10-K filed by the Issuer on August 28, 2026. Excludes pre-funded warrants and warrants held by the Reporting Persons in excess of a beneficial ownership limitation of 4.99%.


SCHEDULE 13G



Coastlands Capital LP
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer of the General Partner, Coastlands Capital LLC
Date:10/14/2026
Coastlands Capital Partners LP
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer of the General Partner, Coastlands Capital GP LLC
Date:10/14/2026
Coastlands Capital GP LLC
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer
Date:10/14/2026
Coastlands Capital LLC
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer
Date:10/14/2026
Matthew D. Perry
Signature:/s/ Matthew D. Perry
Name/Title:Reporting Person
Date:10/14/2026
Exhibit Information

Exhibit 99.1 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1

Categories

SEC Filings